Updates

While medications for opioid use disorder (MOUD) are an effective treatment, most patients with OUD don’t receive them, and prior authorization (PA) has been a barrier to access. Researchers looked at state policies trying to address this barrier, specifically for...

Members of the Sackler family who own Oxycontin maker Purdue Pharma must pay billions of dollars to settle a flood of lawsuits over the harms of opioids, in a new deal formally approved by a federal bankruptcy judge. The Sacklers must contribute up to $7 billion over...

As more states legalize marijuana, use has become more normalized and products have become more potent. But fewer of those who are addicted seek help for it. Pot use among young adults reached historic levels in recent years, according to a federally supported survey....

A U.S. study of more than a million Medicaid enrollees, newly diagnosed with opioid use disorder (OUD), finds most – nearly seven in 10 – are not receiving access to potentially life-saving drugs within six months.  The major gap in access to these medications – vital...

Clinicians should be on alert for signs of medetomidine exposure and withdrawal in suspected overdose cases, public health experts recently said during a CDC webinar. Hosted by the agency’s Division of Overdose Protection, the webinar highlighted growing concerns...